Myriad Genetics
MYGN
#6699
Rank
HK$5.14 B
Marketcap
HK$55.19
Share price
-3.27%
Change (1 day)
-56.65%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$2.76 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are HK$2.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$2.53 B-10.67%
2023-12-31HK$2.83 B16.06%
2022-12-31HK$2.44 B-11.16%
2021-12-31HK$2.75 B
2020-06-30HK$3.76 B1.85%
2019-06-30HK$3.70 B125.43%
2018-06-30HK$1.64 B-52.3%
2017-06-30HK$3.44 B235.02%
2016-06-30HK$1.02 B27.33%
2015-06-30HK$0.80 B-0.66%
2014-06-30HK$0.81 B39.21%
2013-06-30HK$0.58 B36.81%
2012-06-30HK$0.42 B24.45%
2011-06-30HK$0.34 B21.32%
2010-06-30HK$0.28 B13.3%
2009-06-30HK$0.24 B-56.61%
2008-06-30HK$0.57 B108.97%
2007-06-30HK$0.27 B31.97%
2006-06-30HK$0.20 B15.14%
2005-06-30HK$0.18 B53.87%
2004-06-30HK$0.11 B-22.01%
2003-06-30HK$0.15 B-32.22%
2002-06-30HK$0.22 B-12.48%
2001-06-30HK$0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
HK$23.03 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
HK$26.45 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
HK$0.16 B-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.12 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$256.23 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA